Integrating molecular profiling, histological type and other variables: defining the fingerprint of responsiveness to treatment.

@article{Viale2009IntegratingMP,
  title={Integrating molecular profiling, histological type and other variables: defining the fingerprint of responsiveness to treatment.},
  author={Giuseppe Viale},
  journal={Breast},
  year={2009},
  volume={18 Suppl 3},
  pages={
          S32-6
        }
}
The landscape of prognostication and prediction of responsiveness to systemic therapy for breast cancer patients has been recently enriched by the development of molecular assays, which enable to explore the whole universe of gene expression in the tumour cells and to unveil new prognostic and predictive markers. These molecular markers might well be used in combination with the established ones to address the many open questions that still pave the way to a truly personalized treatment. The… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

PET/CT and breast cancer subtypes

VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Survival of de novo stage IV breast cancer patients over three decades

VIEW 1 EXCERPT
CITES METHODS

PET imaging of HER-2-positive tumours

VIEW 1 EXCERPT
CITES BACKGROUND